OpenFilings
BridgeBio Pharma, Inc.
Form
8-K
Report Period
2026-01-14
Date Filed
2026-01-21
Time Filed
16:07:58
Document Analysis
Natural Language Processing
Recognized Type
Unidentified
Defined Term Format
Underlined
Italicized
Bold
Exhibits
8-K
EXHIBIT 4.1
EXHIBIT 99.1
EXHIBIT 99.2
Filing on SEC Edgar